Published in Vaccine Weekly, June 10th, 2009
"The current report characterizes immunogenicity and efficacy for the SIV/CMV Delta vif proviral DNA vaccine when co-inoculated with an optimized rhesus interleukin (rIL)-15 expression plasmid. Macaques co-inoculated with rIL-15 and SIV/CMV Delta vif proviral plasmids showed significantly improved SIV-specific CD8 T cell immunity...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly